4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001437749-22-020338
Director sold 2,504 shares at an average $378.80 ($948,516)
- Director acquired 3,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGGINS JOHN L Director | 2022-08-10 | Option exercise | +3,400 | $66.90 | $227,460 | 8,006 | D |
| HIGGINS JOHN L Director | 2022-08-10 | Sale | −900 | $373.99 | $336,593 | 7,106 | D |
| HIGGINS JOHN L Director | 2022-08-10 | Sale | −100 | $374.90 | $37,490 | 7,006 | D |
| HIGGINS JOHN L Director | 2022-08-10 | Sale | −992 | $380.15 | $377,112 | 6,014 | D |
| HIGGINS JOHN L Director | 2022-08-11 | Sale | −504 | $385.47 | $194,277 | 5,510 | D |
| HIGGINS JOHN L Director | 2022-08-11 | Sale | −8 | $380.71 | $3,046 | 5,502 | D |
| Derivatives | |||||||
| HIGGINS JOHN L Director | 2022-08-10 | Option exercise · Stock Option (right to buy) | −3,400 | 0 | D | ||
| Open-market sales · 2,504 sh · avg $378.80 · $948,516 | |||||||
Loading xslF345X03/rdgdoc.xml…